(Bentham Science Publishers) New oral anticoagulants (NOACs) represent direct-acting drugs functioning selectively for one specific clotting factor. Their clinical indications are the prophylaxis and treatment of deep venous thrombosis and pulmonary embolism, the prevention of atherothrombotic episodes of individuals with acute coronary syndromes and atrial fibrillation
from EurekAlert! - Social and Behavioral Science http://ift.tt/2xVPELg
No comments:
Post a Comment